Loading...
Treatment of Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) comprises a heterogeneous group with pathophysiological, genetic and clinical features. Many patients can be cured with R-CHOP therapy, which is the current standard regimen. Despite recent progress in improving patient survival, the 40% survival of DLBCL patien...
Na minha lista:
| Udgivet i: | J Clin Exp Hematop |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
JSLRT
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144206/ https://ncbi.nlm.nih.gov/pubmed/27980306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.56.79 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|